Skip to content

MDCXW

Medicus Pharma Ltd.

NASDAQ · Healthcare · Biotechnology · CA

$0.31
−6.03%
Ask drillr

Income statement

MetricTTM2025202420232022
Revenue
Total Revenue
Cost of Revenue
Gross Profit
Operating Expenses
R&D Expense20.6M7.7M3.5M193.6K646.4K
SG&A Expense22.7M17.9M7.7M2.5M332.0K
General & Admin Expense22.7M17.9M7.7M2.5M332.0K
Selling & Marketing Expense
Other Expenses(5.5M)(7.3M)2.1M
Total Operating Expenses37.8M18.4M11.2M4.7M978.4K
Cost and Expenses37.8M18.4M11.2M4.7M978.4K
Operating Income (EBIT)(37.8M)(18.4M)(11.2M)(4.7M)(978.4K)
Non-Operating
Interest Income11.6K104.4K10.7K(575.4K)
Interest Expense(30.5K)141.3K317.5K595.5K526.8K
Net Interest Income42.1K(141.3K)(213.1K)(584.8K)(1.1M)
Other Non-Op Income/Expense(1.4M)(7.0M)25.4K(584.8K)(714.0K)
Non-Operating Income (excl Interest)1.5M6.9M(25.4K)(2.1M)187.1K
EBT (Pre-Tax Income)(39.2M)(25.4M)(11.2M)(5.3M)(1.7M)
Income Tax Expense
Bottom Line
Net Income(39.1M)(25.4M)(11.2M)(5.3M)(1.7M)
Earnings from Cont. Ops(39.2M)(25.4M)(11.2M)(5.3M)(1.7M)
Earnings from Discont. Ops
Bottom Line Net Income(51.0M)(33.8M)(11.2M)(5.3M)(1.7M)
Per Share
Basic EPS($1.62)($1.96)($0.69)($0.49)($0.16)
Diluted EPS($1.62)($1.96)($0.69)($0.49)($0.16)
Revenue Per Share$0.00$0.00$0.00$0.00$0.00
Shares
Basic Shares Outstanding55.1M17.3M11.8M8.1M8.1M
Diluted Shares Outstanding55.1M17.3M11.8M8.1M8.1M
Profitability Metrics
EBITDA(39.2M)(25.2M)(11.2M)(586.8K)(1.2M)
D&A2.1M
EBIT(39.2M)(25.2M)(11.2M)(2.7M)(1.2M)

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026